Brief: Celyad H1 Operating Loss Narrows To EUR 15.9 Mln

Celyad Oncology SA

23/08/2019 06:19

Aug 23 (Reuters) - CELYAD SA  CYAD.BR :
    * ANNOUNCED ON THURSDAY H1 OPERATING LOSS EUR 15.9 MLN VS
LOSS EUR
18.8 MLN YR AGO
    * H1 NET CASH USED IN OPERATIONS LOSS EUR 16.1 MLN VS LOSS
EUR
13.9 MLN YR AGO
    * H1 TREASURY POSITION EUR 33.7 MLN VS EUR 62.4 MLN YR AGO
    * THE CO'S LICENSE AND COLLABORATION AGREEMENTS HAVE
GENERATED NO
REVENUE IN FIRST HALF OF 2019
    * WE APPROACH SEVERAL CLINICAL MILESTONES EXPECTED OVER THE
NEXT
SEVERAL MONTHS - CEO

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNX59tYZv
    
 Further company coverage:  CYAD.BR  
   


 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920))